Angioplasty Balloons Market Scope
An angioplasty balloon is a medical device that is used for surgical widening or unblocking of a vessel, particularly an arterial blood vessel. a visible increase in health conditions is discovered thanks to some factors that cause heart-connected diseases like obesity, poor diet, and further sterol. Coronary artery sickness may be a life-threatening sickness that happens thanks to the skimpy offer of blood to the guts, resulting in cardiac arrest. Thus, an individual experiencing such a medical condition ought to be treated with a surgical operation procedure, that cleans the slender and blocked blood veins.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Boston Scientific Corporation (United States), Medtronic PLC (Ireland), Spectranetics Corp. (United States), Becton (United States), Dickinson and Company (C. R. Bard, Inc.) (United States), Abbott Laboratories (United States), Cook Medical, Inc. (United States), Cardinal Health (Cordis) (United States), ENDOCOR GmbH (Germany) and Johnson & Johnson (United States) |
CAGR | % |
Angioplasty Balloons market is a fragmented market due to the presence of various players. Companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance, along with try to incorporate latest technology. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Boston Scientific Corporation (United States), Medtronic PLC (Ireland), Spectranetics Corp. (United States), Becton (United States), Dickinson and Company (C. R. Bard, Inc.) (United States), Abbott Laboratories (United States), Cook Medical, Inc. (United States), Cardinal Health (Cordis) (United States), ENDOCOR GmbH (Germany) and Johnson & Johnson (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Angioplasty Balloons market by Type , by Application (Coronary and Peripheral) and Region with country level break-up.
On the basis of geography, the market of Angioplasty Balloons has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
In 2020, Medtronic plc, the global leader in medical technology acquired France-based Medicrea International, a pioneer in the transformation of surgery through artificial intelligence (AI), predictive modeling, and patient-specific implants. This acquisition will help Medtronic plc for strategic expansion into AI, machine learning, and predictive analytics.
In 2020, Boston Scientific received U.S. Food and Drug Administration (FDA) for launching Ranger Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
Influencing Trend:
Manufacturers Focusing Towards Minimal Evasive Material
Market Growth Drivers:
Factors Such as the Rising Prevalence of Lifestyle-Related Disorders and Increasing Geriatric Populations
Challenges:
The Post-Operational Complications Associated with Angioplasty
Restraints:
High Costs Involved in the Setups and Manufacturing
Opportunities:
Increase in Clinical Development to Advance the Existing Technology
Key Target Audience
Angioplasty Balloons Manufacturer, Providers/Distributors, Research Institutes, End-User Industry and Others